4-hydroxyphenylacetic acid has been researched along with Osteoporosis in 1 studies
4-hydroxyphenylacetic acid : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arns, S | 1 |
| Gibe, R | 1 |
| Moreau, A | 1 |
| Monzur Morshed, M | 1 |
| Young, RN | 1 |
1 other study available for 4-hydroxyphenylacetic acid and Osteoporosis
| Article | Year |
|---|---|
Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
Topics: Alendronate; Animals; Bone and Bones; Bone Density Conservation Agents; Drug Design; Female; Osteopo | 2012 |